The Impact of Artificial Intelligence on Value-Based Care in Orthopaedics

By Michael Awood

October 6, 2023

In healthcare, artificial intelligence has made considerable strides. It has the potential to enhance prediction, diagnosis, and decision-making. Researchers in orthopaedic surgery, where AI technologies have the potential to alter the discipline, have also seen this.

They can apply artificial intelligence in orthopaedics to find trends in data. Predicting patient risk potential or bad occurrences, for example, offers clinicians with crucial information. Despite the label “experimental,” there is mounting evidence that AI is successful and suitable for widespread use.

AI can help physicians and patients collaborate in the next steps. This points to a more cooperative intelligence. Physicians can give patient-specific risk-benefit ratios by feeding patient-reported outcomes into machine-learning algorithms. Doctors can use machine-learning algorithms to expect the results or advantages of arthroplasty surgery. However, we need further research to determine how these choice aids improve outcomes and provide value.

AI use in healthcare is fraught with ethical, legal, regulatory, and practise considerations. How should we get patients’ consent for AI-enabled robotic-assisted procedures? Surgeons must work with programmers to verify that the algorithm outputs match the demands of the patients.

It also poses questions regarding the current medical education programme, ultimately suggesting a redesign. Future professionals must learn to interact with and adapt to this technology for safe use in clinical settings.

However, there is a significant value proposition for AI in healthcare, particularly in terms of cost. AI technologies have the potential to reduce expenses by saving time and resources. These also impact patients’ experiences and outcomes. Getting clinician buy-in for the cultural shift, as well as assessing the initial cost, are essential concerns to balance against these potential savings.

AI has enormous potential in orthopaedics. To explore how artificial intelligence may aid orthopaedic patients, we need to test and assess it in clinics, prioritising its worth. According to the article, value is determined by weighing the advantages of new instruments against their entire expenses.

 

Cover image: stefamerpik on freepik

Reference url

Recent Posts

Advancing Collaborative TB Innovation to Tackle Drug Resistance

By João L. Carapinha

March 24, 2026

Collaborative TB Innovation is essential to ending the world’s deadliest infectious disease. Tuberculosis (TB) still claims millions of lives each year, with rising drug resistance, climate-driven migration, and conflict severely undermining global progress. While the burden falls heaviest on low...
Citation Analysis of Real-World Evidence in Medicare Drug Price Negotiations

By João L. Carapinha

Medicare Drug Price Negotiations are increasingly relying on real-world evidence, according to a new citation analysis of the first drugs selected under the Inflation Reduction Act. The study examined how the Centers for Medicare and Medicaid Services (CMS) uses real-world evidence (RWE) in its M...
Serplulimab Lung Cancer Treatment: Evaluation of Clinical and Economic Impact in Portugal

By João L. Carapinha

Serplulimab lung cancer treatment has received a positive funding recommendation from Portuguese authorities for first-line use in extensive-stage small cell lung cancer (ES-SCLC), despite not demonstrating added therapeutic value over the current standard. No Added Therapeutic Value...